z-logo
open-access-imgOpen Access
Comparison of Pain on Injection of Etomidate versus Etomidate-Lipuro in Patients Undergoing Elective Orthopedic Surgery: A Double-Blind Randomized Clinical Trial
Author(s) -
Alireza Saliminia,
Niloofar Esfahanian
Publication year - 2021
Publication title -
journal of orthopedics and spine trauma
Language(s) - English
Resource type - Journals
eISSN - 2538-4600
pISSN - 2538-2330
DOI - 10.18502/jost.v6i4.5561
Subject(s) - etomidate , medicine , anesthesia , orthopedic surgery , randomized controlled trial , sedative , clinical trial , surgery , propofol
Background: Etomidate is an efficient general anesthetic associated with injection pain. Etomidate-Lipuro is its lipid emulsion, suggested to have less adverse effects. We aim to compare the injection pain of etomidate vs. etomidate-lipuro. Methods: This double-blind randomized clinical trial investigated 46 hands (23 patients) undergoing elective orthopedic surgery referring to our hospital from May to September 2017. For each patient, intravenous (IV) access was put on both hands, on one of which 2 ml of etomidate (drug A) and on the other one, 2 ml of etomidate-lipuro (drug B) were infused simultaneously. Pain scores were compared between drug types by the Wilcoxon signed-rank test using the SPSS software. Results: Among 23 patients included in the study, 8 (34.8%) were female. Mean ± standard deviation (SD) of the patients’ age was 40.52 ± 13.07 years (range: 22-60 years). The type of drug injected to the right hand was drug A in 14 hands (60.9%) and drug B in 9 hands (39.1%). Mean ± SD of pain scores was 3.57 ± 3.30 for drug A (P < 0.001). The hand side (left/right) showed no significant effect on the pain scores (P = 0.535). Conclusion: This randomized clinical trial used each person as his/her own control (left/right hands). Given the results, etomidatelipuro showed significant superiority over etomidate regarding injection pain. In fact, most patients felt no pain, which suggests etomidate-Lipuro as an appropriate sedative.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here